Dammarenediol II
CAS No. 14351-29-2
Dammarenediol II( —— )
Catalog No. M30869 CAS No. 14351-29-2
Dammarenediol II may have the ability to prevent diabetic microvascular complications, including diabetic retinopathy.
Dammarenediol II may have the ability to prevent diabetic microvascular complications, including diabetic retinopathy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 639 | In Stock |
|
50MG | Get Quote | In Stock |
|
100MG | Get Quote | In Stock |
|
Biological Information
-
Product NameDammarenediol II
-
NoteResearch use only, not for human use.
-
Brief DescriptionDammarenediol II may have the ability to prevent diabetic microvascular complications, including diabetic retinopathy.
-
DescriptionDammarenediol II may have the ability to prevent diabetic microvascular complications, including diabetic retinopathy, it can inhibit vascular endothelial growth factor (VEGF)-induced intracellular reactive oxygen species generation and stress fiber formation and vascular endothelial-cadherin disruption. The medicinally important dammarenediol II can be ectopically produced in tobacco, and the production of dammarenediol-II in tobacco plants allows them to adopt a viral defense system.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number14351-29-2
-
Formula Weight444.7
-
Molecular FormulaC30H52O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (112.43 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Parcetasal
Parcetasal is a non-steroidal anti-inflammatory agent that can be used in pain relief studies.
-
Methyl lucidenate A
Methyl lucidenate A is a natural product for research related to life sciences.
-
Influenza NP (147-15...
This peptide is a H2-Db-restricted epitope from Influenza nucleoprotein (147-155).